BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9042255)

  • 1. The effect of tamoxifen on established human colorectal cancer cell lines in vitro.
    Ziv Y; Gupta MK; Milsom JW; Vladisavljevic A; Kitago K; Fazio VW
    Anticancer Res; 1996; 16(6B):3767-71. PubMed ID: 9042255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro.
    Ziv Y; Gupta MK; Milsom JW; Vladisavljevic A; Brand M; Fazio VW
    Anticancer Res; 1994; 14(5A):2005-9. PubMed ID: 7847841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
    Shen F; Xue X; Weber G
    Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth response of colon cancer cell lines to selective estrogen receptor modulators.
    Picariello L; Fiorelli G; Martineti V; Tognarini I; Pampaloni B; Tonelli F; Brandi ML
    Anticancer Res; 2003; 23(3B):2419-24. PubMed ID: 12894523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cells.
    Levine L
    BMC Cancer; 2004 Aug; 4():49. PubMed ID: 15310397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteins excreted by primary human colon carcinoma cells (SW 480) promote spreading and growth of metastatic human colon carcinoma cells (SW 620) in serum-free medium.
    Grimmond HE; Hill GJ; Zirvi KA
    Cancer Biochem Biophys; 1989 Oct; 10(4):353-64. PubMed ID: 2620293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
    Koda M; Jarzabek K; Haczynski J; Knapp P; Sulkowski S; Wolczynski S
    Oncol Rep; 2004 Sep; 12(3):517-21. PubMed ID: 15289830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.
    Xing RH; Mazar A; Henkin J; Rabbani SA
    Cancer Res; 1997 Aug; 57(16):3585-93. PubMed ID: 9270032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
    Calaf GM
    Int J Oncol; 2006 Feb; 28(2):285-95. PubMed ID: 16391781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
    Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
    Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H; Huober J; Wallwiener D; Mueck AO
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does interferon-alpha enhance the effect of tamoxifen-medroxyprogesterone acetate and hydroxyflutamide on in vitro tumor cells?].
    Werner A; Aichberger A; Krebs D
    Zentralbl Gynakol; 1996; 118(11):616-21. PubMed ID: 9082695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma.
    Sampson LK; Vickers SM; Ying W; Phillips JO
    Cancer Res; 1997 May; 57(9):1743-9. PubMed ID: 9135018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin E on tamoxifen-treated breast cancer cells.
    Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
    Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR; Schwartz AM; Shchepotin EI; Uskokovic M; Shchepotin IB
    Clin Cancer Res; 1998 Nov; 4(11):2869-76. PubMed ID: 9829754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.